8.78
Sage Therapeutics Inc Aktie (SAGE) Neueste Nachrichten
SAGE Acquisition Advances as Antitrust Waiting Period Ends - GuruFocus
Supernus announces expiration of HSR waiting period for Sage Therapeutics - TipRanks
Supernus Pharmaceuticals Announces Expiration of - GlobeNewswire
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer - Benzinga
Supernus-Sage $12B Merger Gets Key Regulatory Green Light as Tender Offer Deadline Nears - Stock Titan
Is it the right time to buy Sage Therapeutics Inc. stockFree Wealth Planning Blueprint - jammulinksnews.com
What institutional investors are buying Sage Therapeutics Inc. stockDiscover stocks with explosive growth potential - jammulinksnews.com
What are analysts’ price targets for Sage Therapeutics Inc. in the next 12 monthsFree Stock Market Return Analysis - jammulinksnews.com
What catalysts could drive Sage Therapeutics Inc. stock higher in 2025Access daily stock market expert updates - jammulinksnews.com
How strong is Sage Therapeutics Inc. company’s balance sheetGet expert analysis on top stock picks - jammulinksnews.com
When is Sage Therapeutics Inc. stock expected to show significant growthExplosive trading growth - jammulinksnews.com
What makes Sage Therapeutics Inc. stock price move sharplyAchieve impressive returns with smart timing - jammulinksnews.com
BML Capital Management LLC Acquires Shares of 135,095 Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
Sage Therapeutics (NASDAQ:SAGE) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Sage Therapeutics (SAGE) Expected to Announce Earnings on Wednesday - MarketBeat
Cwm LLC Increases Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat
Is Sage Therapeutics Inc. a good long term investmentOutstanding stock performance - PrintWeekIndia
What drives Sage Therapeutics Inc. stock priceUnbelievable profit margins - Autocar Professional
What analysts say about Sage Therapeutics Inc. stockFree Investment Community - Autocar Professional
Sage Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com
Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace
Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - 富途牛牛
Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, - openPR.com
Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Marinus Pharmac, Pfizer, UCB Biopharma, Rafa Laboratories, Sage Therapeutics - The Globe and Mail
SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc.SAGE - Business Wire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - ACCESS Newswire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):